文献速递产科母胎医学

胎盘植入谱系剖宫产子宫切除术:按外科医生专科评估

Cesarean hysterectomy for placenta accreta spectrum: Surgeon specialty-specific assessment.
PubMed 文献 · Gynecol Oncol · 2024-04-11

基于Premier医疗数据库2016至2020年2240例胎盘植入谱系剖宫产子宫切除术的回顾性研究,按主刀医生专科(普通妇产科、母胎医学、妇科肿瘤)分析临床特征与手术并发症。妇科肿瘤组侵袭性植入比例最高(43.4%),经倾向评分加权后三组手术并发症无显著差异,但总体并发症仍显著。

要点

  • 妇科肿瘤医生处理的胎盘植入谱系中植入性或穿透性胎盘比例最高(43.4%)。
  • 倾向评分加权后三组出血/输血、膀胱损伤等手术并发症无显著差异。
  • 妇科肿瘤医生行剖宫产子宫切除术时出血/输血率仍较高,加做手术未明显降低。

核心结论

  • 数据提示胎盘植入谱系剖宫产子宫切除术的患者特征和手术方式因外科医生专科而异。
  • 妇科肿瘤医生似乎处理更严重类型的胎盘植入谱系。
  • 无论外科医生专科如何,胎盘植入谱系剖宫产子宫切除术的手术并发症均显著。

研究设计与样本

  • 回顾性查询Premier医疗数据库,研究2016至2020年因胎盘植入谱系行剖宫产并同期子宫切除术的患者。
  • 采用基于子宫切除主刀医生专科的倾向评分逆概率处理加权评估手术并发症。
  • 共纳入2240例剖宫产子宫切除术。

主要发现

  • 最常见主刀医生为普通妇产科医生(n=1534,68.5%),其次为妇科肿瘤医生(n=532,23.8%)和母胎医学专科医生(n=174,7.8%)。
  • 植入性或穿透性胎盘比例在妇科肿瘤组最高(43.4%),其次为母胎医学组(39.6%)和普通妇产科组(30.6%)(P < .001)。
  • 倾向评分加权模型中,三组测定的手术并发症相似,包括出血/输血(59.4-63.7%)、膀胱损伤(18.3-24.0%)、输尿管损伤(2.2-4.3%)、休克(8.6-10.5%)和凝血功能障碍(3.3-7.4%)(均P > .05)。
  • 妇科肿瘤医生行剖宫产子宫切除术时,加做手术操作后出血/输血率仍较高:氨甲环酸/输尿管支架(60.4%)、氨甲环酸/血管内操作(76.2%)、输尿管支架/血管内操作(51.6%)及三项操作均做(55.4%)。
  • 氨甲环酸联合输尿管支架置入与膀胱损伤减少相关(12.8% vs 23.8-32.2%,P < .001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess (i) clinical and pregnancy characteristics, (ii) patterns of surgical procedures, and (iii) surgical morbidity associated with cesarean hysterectomy for placenta accreta spectrum based on the specialty of the attending surgeon. METHODS: The Premier Healthcare Database was queried retrospectively to study patients with placenta accreta spectrum who underwent cesarean delivery and concurrent hysterectomy from 2016 to 2020. Surgical morbidity was assessed with propensity score inverse probability of treatment weighting based on surgeon specialty for hysterectomy: general obstetrician-gynecologists, maternal-fetal medicine specialists, and gynecologic oncologists. RESULTS: A total of 2240 cesarean hysterectomies were studies. The most common surgeon type was general obstetrician-gynecologist (n = 1534, 68.5%), followed by gynecologic oncologist (n = 532, 23.8%) and maternal-fetal medicine specialist (n = 174, 7.8%). Patients in the gynecologic oncologist group had the highest rate of placenta increta or percreta, followed by the maternal-fetal medicine specialist and general obstetrician-gynecologist groups (43.4%, 39.6%, and 30.6%, P < .001). In a propensity score-weighted model, measured surgical morbidity was similar across the three subspecialty groups, including hemorrhage / blood transfusion (59.4-63.7%), bladder injury (18.3-24.0%), ureteral injury (2.2-4.3%), shock (8.6-10.5%), and coagulopathy (3.3-7.4%) (all, P > .05). Among the cesarean hysterectomy performed by gynecologic oncologist, hemorrhage / transfusion rates remained substantial despite additional surgical procedures: tranexamic acid / ureteral stent (60.4%), tranexamic acid / endo-arterial procedure (76.2%), ureteral stent / endo-arterial procedure (51.6%), and all three procedures (55.4%). Tranexamic acid administration with ureteral stent placement was associated with decreased bladder injury (12.8% vs 23.8-32.2%, P < .001). CONCLUSION: These data suggest that patient characteristics and surgical procedures related to cesarean hysterectomy for placenta accreta spectrum differ based on surgeon specialty. Gynecologic oncologists appear to manage more severe forms of placenta accreta spectrum. Regardless of surgeon's specialty, surgical morbidity of cesarean hysterectomy for placenta accreta spectrum is significant.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Matsuo K, Huang Y, Matsuzaki S, et al. Cesarean hysterectomy for placenta accreta spectrum: Surgeon specialty-specific assessment. Gynecol Oncol. 2024. PMID: 38603956. doi:10.1016/j.ygyno.2024.04.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。